Vetter M, Holer L, Rothgiesser K, Schonfeld W, et al. Final Overall Survival Analysis of the Phase II SAKK 21/12 Trial of Transdermal CR1447 in Patients With Metastatic Breast Cancer. Clin Breast Cancer 2025 May 24:S1526-8209(25)00146.
PMID: 40537318